Skip to content
healthcare.dev

ROFLUMILAST

NDC 59651-801, ROFLUMILAST, tablet, from Aurobindo Pharma Limited.

Product NDC
59651-801
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213298
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-801 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST250 ug/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
59651-801-20596510801201 BLISTER PACK in 1 CARTON (59651-801-20) / 20 TABLET in 1 BLISTER PACK
59651-801-28596510801281 BLISTER PACK in 1 CARTON (59651-801-28) / 28 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7cb11d48-6bb9-437b-bc7f-382050a2d3e6
  • NADAC price for package 59651080120

    GET /v1/drugs/nadac/59651080120
  • NADAC price for package 59651080128

    GET /v1/drugs/nadac/59651080128

Use it

Look up 59651-801 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-801 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-801. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.